A California-based biotech found some serious success on Wednesday after the company received FDA fast track designation for Troculeucel, used for the treatment of moderate...

To read the full story on AllPennyStocks.com, click here.

NKGen Biotech (NASDAQ:NKGN)
Historical Stock Chart
From May 2025 to Jun 2025 Click Here for more NKGen Biotech Charts.
NKGen Biotech (NASDAQ:NKGN)
Historical Stock Chart
From Jun 2024 to Jun 2025 Click Here for more NKGen Biotech Charts.